1. Home
  2. CCCC vs ARL Comparison

CCCC vs ARL Comparison

Compare CCCC & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$1.89

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

N/A

Current Price

$16.30

Market Cap

258.1M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CCCC
ARL
Founded
2015
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
240.3M
258.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CCCC
ARL
Price
$1.89
$16.30
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.25
N/A
AVG Volume (30 Days)
1.9M
1.5K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.36
Revenue
$30,108,000.00
$49,060,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$45.04
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$9.43
52 Week High
$4.26
$17.00

Technical Indicators

Market Signals
Indicator
CCCC
ARL
Relative Strength Index (RSI) 32.78 54.65
Support Level $1.93 $15.92
Resistance Level $2.13 $16.70
Average True Range (ATR) 0.12 0.39
MACD -0.03 0.02
Stochastic Oscillator 0.00 72.22

Price Performance

Historical Comparison
CCCC
ARL

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: